Enliven Therapeutics

About:

Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.

Website: https://www.enliventherapeutics.com/

Top Investors: OrbiMed, Cormorant Asset Management, Janus Henderson Investors, Fairmount Funds Management, 5AM Ventures

Description:

Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives. The company's discovery process combines clinically validated biological targets and industry-leading chemistry to address the limitations of existing therapies. This approach allows us to efficiently and effectively develop precision oncology therapeutics that enhance overall patient well-being. Founded in July 2019 by Sam Kintz, MBA, Joe Lyssikatos, PhD, and Anish Patel, PharmD, Enliven Therapeutics is based in Boulder, Colorado.